Furthermore, 12 out of 34 bladder cancer cell lines with E2F3 amplification, defined as log2(copy number) ≥1.3, exhibited higher levels of TACC3 mRNA expression (Fig. S1D and Table S1). The gene discussed is E2F3; the disease is urinary bladder cancer.